MES 水合物结构式
|
常用名 | MES 水合物 | 英文名 | MES hydrate |
|---|---|---|---|---|
| CAS号 | 1266615-59-1 | 分子量 | 213.252 | |
| 密度 | N/A | 沸点 | N/A | |
| 分子式 | C6H15NO5S | 熔点 | N/A | |
| MSDS | 美版 | 闪点 | N/A |
| 中文名 | MES 水合物 |
|---|---|
| 英文名 | 2-(4-morpholinyl)ethanesulfonic acid hydrate |
| 英文别名 | 更多 |
| 分子式 | C6H15NO5S |
|---|---|
| 分子量 | 213.252 |
| 精确质量 | 213.067093 |
| 外观性状 | 白色粉末 |
| 储存条件 | 室温 |
| 个人防护装备 | Eyeshields;Gloves |
|---|---|
| 危险品运输编码 | NONH for all modes of transport |
|
A-803467, a tetrodotoxin-resistant sodium channel blocker, modulates ABCG2-mediated MDR in vitro and in vivo.
Oncotarget 6 , 39276-91, (2015) ATP-binding cassette subfamily G member 2 (ABCG2) is a member of the ABC transporter superfamily proteins, which has been implicated in the development of multidrug resistance (MDR) in cancer, apart f... |
|
|
Motesanib (AMG706), a potent multikinase inhibitor, antagonizes multidrug resistance by inhibiting the efflux activity of the ABCB1.
Biochem. Pharmacol. 90(4) , 367-78, (2014) Cancer cells often become resistant to chemotherapy through a phenomenon known as multidrug resistance (MDR). Several factors are responsible for the development of MDR, preeminent among them being th... |
|
|
Design and development of novel mitochondrial targeted nanocarriers, DQAsomes for curcumin inhalation.
Mol. Pharm. 11(7) , 2334-45, (2014) Curcumin has potent antioxidant and anti-inflammatory properties but poor absorption following oral administration owing to its low aqueous solubility. Development of novel formulations to improve its... |
| 2-(4-Morpholinyl)ethanesulfonic acid hydrate (1:1) |
| 4-Morpholineethanesulfonic acid, hydrate (1:1) |
| 2-(4-morpholinyl)ethanesulfonic acid hydrate |
| 2-(Morpholin-4-yl)ethanesulfonic acid hydrate (1:1) |
| EINECS 224-632-3 |
查看所有供应商和价格请点击：